162 related articles for article (PubMed ID: 22374422)
1. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
Zhang C; Tu Z; Du S; Wang Y; Wang Q
Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.
Chu T; Chen X; Yu J; Xiao J; Fu Z
Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
Chen T; Zhu J
Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
[TBL] [Abstract][Full Text] [Related]
5. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
7. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
8. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
Tickoo SK; Hutchinson B; Bacik J; Mazumdar M; Motzer RJ; Bajorin DF; Bosl GJ; Reuter VE
Int J Surg Pathol; 2002 Jan; 10(1):23-32. PubMed ID: 11927966
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.
Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L
PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431
[TBL] [Abstract][Full Text] [Related]
10. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Bi XC; Liu JM; Zheng XG; Xian ZY; Feng ZW; Lou YX; Zhong WD; Wu CL
Clin Invest Med; 2011 Dec; 34(6):E358. PubMed ID: 22129926
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
[TBL] [Abstract][Full Text] [Related]
13. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
14. Clinically atypical seminomas with yolk sac tumor features.
Som A; Xiao L; Zhu R; Guo CC; Xiao L; Rao P; Efstathiou E; Matin A; Tu SM
Can J Urol; 2013 Aug; 20(4):6860-7. PubMed ID: 23930614
[TBL] [Abstract][Full Text] [Related]
15. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma.
Arai E; Nakagawa T; Wakai-Ushijima S; Fujimoto H; Kanai Y
Histopathology; 2012 May; 60(6B):E12-8. PubMed ID: 22394436
[TBL] [Abstract][Full Text] [Related]
17. GOLPH2 expression may serve as diagnostic marker in seminomas.
Fritzsche FR; Kristiansen G; Riener MO; Dietel M; Oelrich B
BMC Urol; 2010 Feb; 10():4. PubMed ID: 20184749
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors.
Fukuoka M; Hamasaki M; Koga K; Hayashi H; Aoki M; Kawarabayashi T; Miyamoto S; Nabeshima K
Virchows Arch; 2012 Oct; 461(4):457-66. PubMed ID: 22926487
[TBL] [Abstract][Full Text] [Related]
19. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
[TBL] [Abstract][Full Text] [Related]
20. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
